GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Total Liabilities

InMode (InMode) Total Liabilities : $75.9 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is InMode Total Liabilities?

InMode's Total Liabilities for the quarter that ended in Dec. 2023 was $75.9 Mil.

InMode's quarterly Total Liabilities increased from Jun. 2023 ($67.93 Mil) to Sep. 2023 ($70.03 Mil) and increased from Sep. 2023 ($70.03 Mil) to Dec. 2023 ($75.91 Mil).

InMode's annual Total Liabilities increased from Dec. 2021 ($62.74 Mil) to Dec. 2022 ($89.79 Mil) but then declined from Dec. 2022 ($89.79 Mil) to Dec. 2023 ($75.91 Mil).


InMode Total Liabilities Historical Data

The historical data trend for InMode's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Total Liabilities Chart

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 38.58 40.29 62.74 89.79 75.91

InMode Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.79 66.63 67.93 70.03 75.91

InMode Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

InMode's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=64.136+(6.613+1.399
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+3.766+0)
=75.9

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=863.286-787.372
=75.9

InMode's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=64.136+(6.613+1.399
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+3.766+0)
=75.9

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=863.286-787.372
=75.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InMode Total Liabilities Related Terms

Thank you for viewing the detailed overview of InMode's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


InMode (InMode) Business Description

Traded in Other Exchanges
Address
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.